These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26462434)

  • 1. Myeloid-derived suppressor cells in human peripheral blood: Optimized quantification in healthy donors and patients with metastatic renal cell carcinoma.
    Flörcken A; Takvorian A; Singh A; Gerhardt A; Ostendorf BN; Dörken B; Pezzutto A; Westermann J
    Immunol Lett; 2015 Dec; 168(2):260-7. PubMed ID: 26462434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of human myeloid-derived suppressor cells after blood draw.
    Grützner E; Stirner R; Arenz L; Athanasoulia AP; Schrödl K; Berking C; Bogner JR; Draenert R
    J Transl Med; 2016 Jan; 14():2. PubMed ID: 26733325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-derived suppressor cell accumulation in renal cell carcinoma is correlated with CCL2, IL-17 and IL-18 expression in blood and tumors.
    Guan X; Liu Z; Zhang J; Jin X
    Adv Clin Exp Med; 2018 Jul; 27(7):947-953. PubMed ID: 29905412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in both CD14-positive and CD15-positive myeloid-derived suppressor cell subpopulations in the blood of patients with glioma but predominance of CD15-positive myeloid-derived suppressor cells in glioma tissue.
    Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Petersen-Baltussen HM; ter Laan M; Wesseling P; Adema GJ
    J Neuropathol Exp Neurol; 2015 May; 74(5):390-400. PubMed ID: 25853692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.
    Finke J; Ko J; Rini B; Rayman P; Ireland J; Cohen P
    Int Immunopharmacol; 2011 Jul; 11(7):856-61. PubMed ID: 21315783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy.
    Chen HM; Ma G; Gildener-Leapman N; Eisenstein S; Coakley BA; Ozao J; Mandeli J; Divino C; Schwartz M; Sung M; Ferris R; Kao J; Wang LH; Pan PY; Ko EC; Chen SH
    Clin Cancer Res; 2015 Sep; 21(18):4073-4085. PubMed ID: 25922428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-derived suppressors cells (MDSC) correlate with clinicopathologic factors and pathologic complete response (pCR) in patients with urothelial carcinoma (UC) undergoing cystectomy.
    Ornstein MC; Diaz-Montero CM; Rayman P; Elson P; Haywood S; Finke JH; Kim JS; Pavicic PG; Lamenza M; Devonshire S; Dann P; Schach K; Stephenson A; Campbell S; Emamekhoo H; Ernstoff MS; Hoimes CJ; Gilligan TD; Rini BI; Garcia JA; Grivas P
    Urol Oncol; 2018 Sep; 36(9):405-412. PubMed ID: 29606341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myeloid-derived suppressor cells in patients with breast cancer].
    Gonda K; Shibata M; Ohtake T; Yasuda M; Abe N; Watanabe K; Ando J; Okano M; Onozawa H; Tachibana K; Ohto H; Takenoshita S
    Gan To Kagaku Ryoho; 2012 Sep; 39(9):1363-8. PubMed ID: 22996770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.
    Kotsakis A; Harasymczuk M; Schilling B; Georgoulias V; Argiris A; Whiteside TL
    J Immunol Methods; 2012 Jul; 381(1-2):14-22. PubMed ID: 22522114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells.
    Luyckx A; Schouppe E; Rutgeerts O; Lenaerts C; Fevery S; Devos T; Dierickx D; Waer M; Van Ginderachter JA; Billiau AD
    Clin Immunol; 2012 Apr; 143(1):83-7. PubMed ID: 22341087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study.
    Mandruzzato S; Brandau S; Britten CM; Bronte V; Damuzzo V; Gouttefangeas C; Maurer D; Ottensmeier C; van der Burg SH; Welters MJ; Walter S
    Cancer Immunol Immunother; 2016 Feb; 65(2):161-9. PubMed ID: 26728481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma.
    Ochoa AC; Zea AH; Hernandez C; Rodriguez PC
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):721s-726s. PubMed ID: 17255300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients.
    Heuvers ME; Muskens F; Bezemer K; Lambers M; Dingemans AC; Groen HJM; Smit EF; Hoogsteden HC; Hegmans JPJJ; Aerts JGJV
    Lung Cancer; 2013 Sep; 81(3):468-474. PubMed ID: 23850196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of endostatin gene therapy on myeloid-derived suppressor cells from a metastatic renal cell carcinoma.
    Chaves KC; Costa EM; Teixeira LF; Bellini MH
    Exp Oncol; 2018 Mar; 40(1):24-32. PubMed ID: 29600976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of myeloid-derived suppressor cells and efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma patients.
    Wang Z; Zhang Y; Liu Y; Wang L; Zhao L; Yang T; He C; Song Y; Gao Q
    J Immunother; 2014 Jan; 37(1):43-50. PubMed ID: 24316555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells.
    Apodaca MC; Wright AE; Riggins AM; Harris WP; Yeung RS; Yu L; Morishima C
    J Immunother Cancer; 2019 Aug; 7(1):230. PubMed ID: 31462270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells.
    Vollbrecht T; Stirner R; Tufman A; Roider J; Huber RM; Bogner JR; Lechner A; Bourquin C; Draenert R
    AIDS; 2012 Jul; 26(12):F31-7. PubMed ID: 22526518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic changes in myeloid derived suppressor cell subsets following renal transplant: A prospective study.
    Hock BD; McKenzie JL; Cross NB; Currie MJ
    Transpl Immunol; 2015 Jun; 32(3):164-71. PubMed ID: 25968653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.
    Rodriguez PC; Ernstoff MS; Hernandez C; Atkins M; Zabaleta J; Sierra R; Ochoa AC
    Cancer Res; 2009 Feb; 69(4):1553-60. PubMed ID: 19201693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells.
    Hock BD; Mackenzie KA; Cross NB; Taylor KG; Currie MJ; Robinson BA; Simcock JW; McKenzie JL
    Nephrol Dial Transplant; 2012 Jan; 27(1):402-10. PubMed ID: 21617199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.